Long-term administration of sorafenib and initial dosage per body weight are associated with overall survival in patients with unresectable advanced hepatocellular carcinoma
Long-term administration of sorafenib and initial dosage per body weight are associated with overall survival in patients with unresectable advanced hepatocellular carcinoma
复制标题
索拉非尼的长期给药和单位体重的初始剂量与不可切除的晚期肝细胞癌患者的总生存期相关
DOI：
--
复制
发表时间：
2011
期刊：
影响因子：
--
通讯作者：
et al
中科院分区：
文献类型：
--
作者：
Hiramine Y;Uto H;et al
